The Europe Non-Emergency Medical Transportation Market size is expected to reach US$ 9,037.6 Million by 2031 from US$ 4,786.3 Million in 2024. The market is estimated to record a CAGR of 9.5% from 2025 to 2031.
Executive Summary and Europe Non-Emergency Medical Transportation Market Analysis:The European non-emergency medical transportation (NEMT) market, divided into the UK, Germany, France, Italy, Spain, and the Rest of Europe, is growing consistently and is the second-largest market in the world. The sector mainly grows with the rising incidence of chronic and life-threatening diseases like cancer, cardiovascular disease, and renal disease, which necessitate patients to visit hospitals and clinics repeatedly. The area's fast-deteriorating population structure and increasing number of people with physical impairments are also adding to the increasing need for safe, accessible, and reliable transportation services.
Germany and the UK lead the market with highly developed healthcare systems, well-established reimbursement models, and strong patient mobility awareness. Southern European countries are demonstrating gradual growth based on government healthcare programs. Further, integration of technology in scheduling, tracking, and fleet management is increasing service effectiveness and patient satisfaction in Europe.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Non-Emergency Medical Transportation Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- By Service Type, the Europe Non-Emergency Medical Transportation Market is segmented into Private Pay Patient Transportation, Insurance Backed Patient Transportation, Courier Services, and Others. Private Pay Patient Transportation held the largest share of the market in 2024.
- By Facility, the Europe Non-Emergency Medical Transportation Market is segmented into Intra-Facility and Inter-Facility. Inter-Facility held a larger share of the market in 2024.
- By Application, the Europe Non-Emergency Medical Transportation Market is segmented into Dialysis, Routine Doctor Visits, Mental Health Related Appointments, Rehabilitation, and Others. Mental Health Related Appointments held the largest share of the market in 2024.
- By End User, the Europe Non-Emergency Medical Transportation Market is segmented into Hospitals and Clinics, Nursing Homes, Homecare Settings, MCO and State Agencies, Healthcare Payers, and Others. Hospitals and Clinics held the largest share of the market in 2024.
Chronically ill patients can be the main concern for family members. In addition to taking care of recurring medical expenses, family members also need to be proactive in arranging transportation, as these patients require regular access to life-saving health services. Managing chronic diseases necessitates regular clinician visits, access to medications, and adjustments to treatment plans to ensure evidence-based care. However, without proper transportation, delays in clinical interventions are unavoidable. Such delays in care can cause exacerbations of chronic conditions or unmet healthcare needs, ultimately resulting in adverse health outcomes. This highlights the urgent need for reliable patient transportation, particularly for patients with terminal illnesses requiring consistent post-acute care management. The World Health Organization (WHO) reported in 2023 that the population aged 60 and older is expected to reach 2.1 billion by 2050. This increase will come with a sharp rise in chronic diseases like diabetes, heart disease, and arthritis. As a result, more people need non-emergency medical transportation around the world. Patients often require regular access to healthcare facilities for ongoing treatment and management. Therefore, the aging population and chronic conditions are major factors driving the growth of non-emergency medical transportation services.
While some people might need therapies on a daily basis, many visit their physicians for weekly consultations. Additionally, several chronic diseases, such as arthritis, heart disease, and neurological conditions, can result in temporary or permanent immobility. Many individuals suffering from chronic conditions find it difficult to drive or use public transportation to access healthcare. Arranging a separate car may not be viable, especially for families belonging to low-income groups who do not own any vehicle. NEMT proves to be of great help to people, as these transportation options are cost-effective and specifically designed to cater to people with mobility challenges and medical needs. In addition, the easy availability of NEMT allows individuals with chronic medical conditions to access life-sustaining treatments and healthcare services without any delay.
As the population ages, the demand for healthcare services has skyrocketed. There is an increase in older adults requiring medical care, ranging from routine check-ups to treatments for chronic conditions (diabetes, hypertension, arthritis, and physical therapy). Any missed appointments can cause disease progression and limit the patient's ability to manage their conditions. Older adults often face mobility challenges, making reliable transportation with specialized vehicles and trained personnel essential to ensure they can access necessary medical appointments. NEMT provides a reliable way to attend appointments, reducing the possibility of missing appointments due to transportation barriers. Thus, the increase in the aging population and chronic conditions bolsters the growth of the non-emergency medical transportation market.
Europe Non-Emergency Medical Transportation Market Country InsightsBy country, the Europe Non-Emergency Medical Transportation Market is segmented into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany held the largest share in 2024.
According to the UN Population Division Report, Germany's population aged 65 years and older is projected to increase by 41% and is expected to reach 24 million by 2050, accounting for approximately one-third of the total population. Germany is a leading figure in the fight against mental illness in Europe. The country has established ways for the diagnosis and treatment of mental illness in citizens and has prioritized the mental health of all Germans since the 1990s. Germany has a similar rate of mental illness to other developed nations, with approximately 31% of Germans diagnosed with at least one mental disorder. Unlike most developed nations, depression and anxiety are the highest among adults, but they are formed at a young age. According to the German Center for Mental Health (DZPG) 2024 report, up to 20% of the children and adolescents in Germany suffer from mental disorders.
According to the German Federal Statistical Office, 7.8 million severely disabled people lived in Germany in 2022, accounting for 9.4% of the total German population.
Europe Non-Emergency Medical Transportation Market Company ProfilesSome of the key players operating in the market include AMR, ABC Non-Emergency Medical Transportation, LLC, MTM, Inc., Xpress Transportation, CJ Medical Transportation, VERIDA, Elite Medical Transport, Acadian Ambulance Service, Crothall Healthcare, ModivCare, Ride Health, Roundtrip, Transdev, One Call, Medical Answering Services, LLC, Abba Medical Transportation, LLC, Able Medical Transportation, Inc., Life Ride, Stellar Transport, and Mobility Transportation Services, Inc.
These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Europe Non-Emergency Medical Transportation Market Research MethodologyThe following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites,
annual reports, financial statements, broker analyses, and investor presentationsIndustry trade journals
and other relevant publicationsGovernment documents,
statistical databases, and market reportsNews articles,
press releases, and webcasts specific to companies operating in the market
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.Primary Research
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders:
Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales ManagersExternal experts:
Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Non-Emergency Medical Transportation Market Landscape
4.1 Market Overview
4.2 PEST Analysis
5. Europe Non-Emergency Medical Transportation Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Non-Emergency Medical Transportation Market - Europe Market Analysis
6.1 Europe Non-Emergency Medical Transportation Market Revenue (US$ Million), 2024 - 2031
6.2 Europe Non-Emergency Medical Transportation Market Forecast and Analysis
7. Europe Non-Emergency Medical Transportation Market Revenue Analysis - by Service Type
7.1 Private Pay Patient Transportation
7.1.1 Overview
7.1.2 Private Pay Patient Transportation: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Insurance Backed Patient Transportation
7.2.1 Overview
7.2.2 Insurance Backed Patient Transportation: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Courier Services
7.3.1 Overview
7.3.2 Courier Services: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. Europe Non-Emergency Medical Transportation Market Revenue Analysis - by Facility
8.1 Intra-Facility
8.1.1 Overview
8.1.2 Intra-Facility: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Inter-Facility
8.2.1 Overview
8.2.2 Inter-Facility: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. Europe Non-Emergency Medical Transportation Market Revenue Analysis - by Application
9.1 Dialysis
9.1.1 Overview
9.1.2 Dialysis: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Routine Doctor Visits
9.2.1 Overview
9.2.2 Routine Doctor Visits: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Mental Health Related Appointments
9.3.1 Overview
9.3.2 Mental Health Related Appointments: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Rehabilitation
9.4.1 Overview
9.4.2 Rehabilitation: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. Europe Non-Emergency Medical Transportation Market Revenue Analysis - by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Nursing Homes
10.2.1 Overview
10.2.2 Nursing Homes: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Homecare Settings
10.3.1 Overview
10.3.2 Homecare Settings: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 MCO and State Agencies
10.4.1 Overview
10.4.2 MCO and State Agencies: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Healthcare Payers
10.5.1 Overview
10.5.2 Healthcare Payers: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. Europe Non-Emergency Medical Transportation Market - Country Analysis
11.1 Europe
11.1.1 Europe Non-Emergency Medical Transportation Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Europe Non-Emergency Medical Transportation Market Revenue and Forecast and Analysis - by Country
11.1.2.2 Germany: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 Germany: Europe Non-Emergency Medical Transportation Market Share - by Service Type
11.1.2.2.2 Germany: Europe Non-Emergency Medical Transportation Market Share - by Facility
11.1.2.2.3 Germany: Europe Non-Emergency Medical Transportation Market Share - by Application
11.1.2.2.4 Germany: Europe Non-Emergency Medical Transportation Market Share - by End User
11.2.3.3 United Kingdom: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 United Kingdom: Europe Non-Emergency Medical Transportation Market Share - by Service Type
11.2.3.3.2 United Kingdom: Europe Non-Emergency Medical Transportation Market Share - by Facility
11.2.3.3.3 United Kingdom: Europe Non-Emergency Medical Transportation Market Share - by Application
11.2.3.3.4 United Kingdom: Europe Non-Emergency Medical Transportation Market Share - by End User
11.3.4.4 France: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 France: Europe Non-Emergency Medical Transportation Market Share - by Service Type
11.3.4.4.2 France: Europe Non-Emergency Medical Transportation Market Share - by Facility
11.3.4.4.3 France: Europe Non-Emergency Medical Transportation Market Share - by Application
11.3.4.4.4 France: Europe Non-Emergency Medical Transportation Market Share - by End User
11.4.5.5 Italy: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Italy: Europe Non-Emergency Medical Transportation Market Share - by Service Type
11.4.5.5.2 Italy: Europe Non-Emergency Medical Transportation Market Share - by Facility
11.4.5.5.3 Italy: Europe Non-Emergency Medical Transportation Market Share - by Application
11.4.5.5.4 Italy: Europe Non-Emergency Medical Transportation Market Share - by End User
11.5.6.6 Spain: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.5.6.6.1 Spain: Europe Non-Emergency Medical Transportation Market Share - by Service Type
11.5.6.6.2 Spain: Europe Non-Emergency Medical Transportation Market Share - by Facility
11.5.6.6.3 Spain: Europe Non-Emergency Medical Transportation Market Share - by Application
11.5.6.6.4 Spain: Europe Non-Emergency Medical Transportation Market Share - by End User
11.6.7.7 Rest of Europe: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.6.7.7.1 Rest of Europe: Europe Non-Emergency Medical Transportation Market Share - by Service Type
11.6.7.7.2 Rest of Europe: Europe Non-Emergency Medical Transportation Market Share - by Facility
11.6.7.7.3 Rest of Europe: Europe Non-Emergency Medical Transportation Market Share - by Application
11.6.7.7.4 Rest of Europe: Europe Non-Emergency Medical Transportation Market Share - by End User
12 Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 Industry Landscape
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 AMR
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ABC Non-Emergency Medical Transportation, LLC
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 MTM, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Xpress Transportation
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 CJ Medical Transportation
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 VERIDA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Elite Medical Transport
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Acadian Ambulance Service
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Crothall Healthcare
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 ModivCare
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Ride Health
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Roundtrip
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Transdev
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments
14.14 One Call
14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments
14.15 Medical Answering Services, LLC
14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments
14.16 Abba Medical Transportation, LLC
14.16.1 Key Facts
14.16.2 Business Description
14.16.3 Products and Services
14.16.4 Financial Overview
14.16.5 SWOT Analysis
14.16.6 Key Developments
14.17 Able Medical Transportation, Inc.
14.17.1 Key Facts
14.17.2 Business Description
14.17.3 Products and Services
14.17.4 Financial Overview
14.17.5 SWOT Analysis
14.17.6 Key Developments
14.18 Life Ride
14.18.1 Key Facts
14.18.2 Business Description
14.18.3 Products and Services
14.18.4 Financial Overview
14.18.5 SWOT Analysis
14.18.6 Key Developments
14.19 Stellar Transport
14.19.1 Key Facts
14.19.2 Business Description
14.19.3 Products and Services
14.19.4 Financial Overview
14.19.5 SWOT Analysis
14.19.6 Key Developments
14.20 Mobility Transportation Services, Inc.
14.20.1 Key Facts
14.20.2 Business Description
14.20.3 Products and Services
14.20.4 Financial Overview
14.20.5 SWOT Analysis
14.20.6 Key Developments
15. Appendix
15.1 About The Insight Partners
List of Tables
Table 1. Europe Non-Emergency Medical Transportation Market Segmentation
Table 2. List of Vendors
Table 3. Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 5. Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 6. Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 7. Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 8. Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. Germany: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 10. Germany: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 11. Germany: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 12. Germany: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 13. United Kingdom: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 14. United Kingdom: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 15. United Kingdom: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Kingdom: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. France: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 18. France: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 19. France: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 20. France: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Italy: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 22. Italy: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 23. Italy: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 24. Italy: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Spain: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 26. Spain: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 27. Spain: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 28. Spain: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Rest of Europe: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 30. Rest of Europe: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Facility
Table 31. Rest of Europe: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 32. Rest of Europe: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 33. Heat Map Analysis by Key Players
List of Figures
Figure 1. Europe Non-Emergency Medical Transportation Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Non-Emergency Medical Transportation Market
Figure 4. Europe Non-Emergency Medical Transportation Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Europe Non-Emergency Medical Transportation Market Revenue (US$ Million), 2024 - 2031
Figure 7. Europe Non-Emergency Medical Transportation Market Share (%) - by Service Type, 2024 and 2031
Figure 8. Private Pay Patient Transportation: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Insurance Backed Patient Transportation: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Courier Services: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Others: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Europe Non-Emergency Medical Transportation Market Share (%) - by Facility, 2024 and 2031
Figure 13. Intra-Facility: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Inter-Facility: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Europe Non-Emergency Medical Transportation Market Share (%) - by Application, 2024 and 2031
Figure 16. Dialysis: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Routine Doctor Visits: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Mental Health Related Appointments: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Rehabilitation: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Others: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Europe Non-Emergency Medical Transportation Market Share (%) - by End User, 2024 and 2031
Figure 22. Hospitals and Clinics: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Nursing Homes: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Homecare Settings: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. MCO and State Agencies: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Healthcare Payers: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Others: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Europe Non-Emergency Medical Transportation Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. Germany: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. United Kingdom: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. France: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Italy: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. Spain: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Rest of Europe: Europe Non-Emergency Medical Transportation Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Company Positioning & Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Nov 2025
MRI-guided Focused Ultrasound Therapy Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Breast Cancer, Prostate Cancer, Liver Cancer, Pancreatic Cancer, Breast Lifting and Aesthetic Application, Nipple and Areola Preservation, Post Surgical Applications, and Others), End User (Healthcare Facilities, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Gene Therapy CDMO Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Other Service Types), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
RT-PCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Nov 2025
dPCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Nov 2025
Oscillometry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Device and Accessories), Technology (Impulse Oscillometry, Forced Oscillation Technique, and Hybrid Oscillometry Devices), Application (Asthma, COPD, and Others), End User (Hospitals, Diagnostic Laboratories, and Others)
Nov 2025
Prenatal Testing Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Diagnostic Type (Noninvasive and Invasive), Disease (Aneuploidy, Microdeletions, Structural Chromosomal Abnormalities, and Others), End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
Nov 2025
Joint Resurfacing Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Knee, Hip, Shoulder, Ankle, and Others), Material (Metal, Ceramic, and Others), End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America)
Nov 2025
Embolization Plugs Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Neurology, Peripheral Vascular Disease, Oncology, Urology, and Others), End User (Hospital, Ambulatory Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

Get Free Sample For